Lamborghini announced it is collaborating with Houston Methodist Research Institute (HMRI) on a study focused on a biocompatibility study of composite materials to be used mainly in prosthetic implants and subcutaneous devices. The aim is to identify new materials that are lighter, better tolerated by the human body, and more resistant over time than those currently used in the medical field.
Automobili Lamborghini is a leader in the research and production of carbon fiber composite materials, and the Advanced Composite Lightweight Structures Department of Research & Development provides its experience not only in the automotive field but also in other sectors including biomedical.
HMRI is the latest in a list of medical research facilities with which Lamborghini is collaborating on various projects. The company’s other Italian biomedical partners include with the Occupational Medicine Unit of Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic, the Neurosurgery of IRCCS Institute of Neurological Sciences of Bologna, the Neurosurgery Humanitas University Rozzano-Milano, the CNR Institute of Neuroscience and Humanitas and IRCSS Rizzoli Orthopedic Institute of Bologna.
Lamborghini’s research partnerships also extend to the U.S. The company is also continuing its research on its signature forged carbon fiber composites at a lab near Seattle. Unlike traditional carbon fiber, which is made up of sheets of materials, forged carbon composite simply uses a paste of carbon fibers that can be molded into a wide array of shapes. The company plans on using forged carbon fiber for a number of different applications, including connecting rods in a V-12 engine.
The forged composites are also being applied to separate research projects with MIT and with Mitsubishi Rayon to develop high-performance sports cars.